Your browser doesn't support javascript.
loading
Early versus late parenteral nutrition in term and late preterm infants: study protocol for a randomised controlled trial.
Moon, Kwi; Mckinnon, Elizabeth; Croft, Kevin; Hendrie, Delia; Patole, Sanjay; Simmer, Karen; Rao, Shripada.
Afiliação
  • Moon K; Pharmacy Department, Perth Children's Hospital, 15 Hospital Ave, Nedlands, WA, 6009, Australia. Kwi.Moon@health.wa.gov.au.
  • Mckinnon E; Medical School, The University of Western Australia, Perth, WA, Australia. Kwi.Moon@health.wa.gov.au.
  • Croft K; Telethon Kids Institute, Nedlands, WA, Australia.
  • Hendrie D; School of Biomedical Sciences, The University of Western Australia, Perth, WA, Australia.
  • Patole S; School of Public Health Sciences, Curtin University, Perth, WA, Australia.
  • Simmer K; Medical School, The University of Western Australia, Perth, WA, Australia.
  • Rao S; Department of Neonatology, King Edward Memorial Hospital, Subiaco, WA, Australia.
BMC Pediatr ; 22(1): 514, 2022 08 30.
Article em En | MEDLINE | ID: mdl-36042439
ABSTRACT

BACKGROUND:

Despite the wide use of parenteral nutrition (PN) in neonatal intensive care units (NICU), there is limited evidence regarding the optimal time to commence PN in term and late preterm infants. The recommendations from the recently published ESPGHAN/ESPEN/ESPR/CPEN and NICE guidelines are substantially different in this area, and surveys have reported variations in clinical practice. The aim of this randomised controlled trial (RCT) is to evaluate the benefits and risks of early versus late PN in term and late preterm infants. METHODS/

DESIGN:

This study is a single-centre, non-blinded RCT in the NICU of Perth Children's Hospital, Western Australia.A total of 60 infants born ≥34 weeks of gestation who have a high likelihood of intolerance to enteral nutrition (EN) for at least 3-5 days will be randomised to early (day 1 or day 2 of admission) or late commencement (day 6 of admission) of PN after informed parental consent. In both groups, EN will be commenced as early as clinically feasible. Primary outcomes are plasma phenylalanine and plasma F2-isoprostane levels on Day 4 and Day 8 of admission. Secondary outcomes are total and individual plasma amino acid profiles, plasma and red blood cell fatty acid profiles, in-hospital all-cause mortality, hospital-acquired infections, length of hospital/NICU stay, z scores and changes in z scores at discharge for weight, height and head circumference, time to full EN, duration of respiratory (mechanical, non-invasive) support, duration of inotropic support, the incidence of hyper and hypoglycaemia, incidence of metabolic acidosis, liver function, blood urea nitrogen, and C-reactive protein (CRP).

DISCUSSION:

This RCT will examine the effects of early versus late PN in term and late preterm infants by comparing key biochemical and clinical outcomes and has the potential to identify underlying pathways for beneficial or harmful effects related to the timing of commencement of PN in such infants. TRIAL REGISTRATION ANZCTR; ACTRN12620000324910 (3rd March 2020).
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Recém-Nascido Prematuro / Nutrição Parenteral Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies / Qualitative_research Limite: Humans / Newborn Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Recém-Nascido Prematuro / Nutrição Parenteral Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies / Qualitative_research Limite: Humans / Newborn Idioma: En Ano de publicação: 2022 Tipo de documento: Article